The unicorn killer: Why regulatory risk keeps destroying startup value and what to do about it | Fortune
Briefly

The unicorn killer: Why regulatory risk keeps destroying startup value and what to do about it | Fortune
"Private equity and venture capital firms spend months analyzing market dynamics, competitive landscapes, and management teams before writing checks. They stress-test financial models, conduct extensive due diligence, and negotiate protective covenants. But many are underestimating one of the biggest threats to their portfolio returns: regulatory and narrative risk-policy decisions, enforcement shifts, and public backlash that can derail even the strongest business models overnight."
"AI chipmaker Cerebras Systems filed for its highly anticipated IPO last September, expecting to raise $1 billion at an $8 billion valuation. The company burned through cash for months in regulatory limbo, its national security review frozen due to federal staffing bottlenecks. When Cerebras finally cleared the Committee on Foreign Investment in the United States (CFIUS) review in March 2025, the market had already moved on. But that's the dirty secret of regulatory delays; they don't just pause deals, they poison them."
"After going public via a special purpose acquisition company (SPAC) in 2021, one major dockless scooter firm was so overwhelmed by municipal regulatory battles across the United States and Europe that it was delisted from the New York Stock Exchange in September 2023 because its market cap fell below $15 million before filing for bankruptcy three months later. Another industry leader suffered a particularly devastating blow when Paris, its most profitable market, banned e-scooters entirely in 2023 following a public referendum."
Private equity and venture capital firms prioritize detailed market, competitive, and management analysis, stress-testing financial models, and negotiating covenants. Many firms underestimate regulatory and narrative risk, including policy changes, enforcement shifts, and public backlash that can rapidly undermine business models. Regulatory delays can consume cash and worsen market timing, as exemplified by Cerebras' IPO limbo and eventual CFIUS clearance arriving after market interest waned. Urban micromobility companies saw multibillion-dollar valuations collapse when cities banned or restricted services, producing delistings and bankruptcies. Local rules such as fleet caps and speed throttles can severely reduce consumer utility and commercial viability.
Read at Fortune
Unable to calculate read time
[
|
]